Create a communication strategy that fosters change and innovation in an organization. Explain the context in which it occurs and the options that are available. Develop a solution that will solve the organizational issue and meet the needs of the people involved.
Feel free to use the same organization you researched for the Unit VI and Unit VII Assignments. You are not limited to this organization, but it may be easier to complete the assignment since you have already researched it for Unit VI and/or Unit VII. You can use the same sources for all assignments, if applicable.
In the report, you will provide a potential audience analysis, create a purposeful message, and discuss a type of channel that you could use for feedback. Include answers to Neal’s (2010) communication questions, which are listed below:
What am I trying to achieve?
How will my audience react to what I am trying to achieve?
Will my message be resisted?
What do I know about my audience that will help me tailor my message? (p. 40)
Do not include the question/answers in a bullet or list format. Instead, integrate the responses in your paragraphs.
negotiated down to what is deemed appropriate and feasible. Similar to the FDA, the European Commision approves drugs but what makes their system different is that they have a separate body called the National Institute for Health and Social Care Excellence (NICE) who is responsible for determining a drug’s cost effectiveness and clinical benefits(Nawrat). Canada also utilizes a single-payer system for healthcare is therefore in control of the country’s drug prices (Amadeo). Canada established a Patented Medicine Prices Review Board that encourages pharmaceutical companies to suggest a price proposal for their manufactured drugs. This review board then compares the suggested price to various other countries with similar drugs. Approval is made depending on the cost of the drugs in other countries. Despite Canada’s single payer system, the country lacks universal drug coverage but due to their current system, the costs of prescription drugs in Canada remain cheaper than the cost in the United States (Morgan et al). In addition, Spain is another country that continuously aims to lower drug prices by utilizing reference pricing. Reference pricing is a system in which similar of identical drugs are categorized into a class. This allows for the insurer to pay one price for any of the drugs included within the given class. However, a pharmaceutical companies in Spain have the option of increasing drug costs thus requiring individuals to pay the difference between insurer costs and pharmaceutical company demands. Despite this, Spain has found that reference pricing often forces pharmaceutical companies to lower prices in order to maintain consumer business. Reference pricing has greatly assisted with cost-effectiveness by selling normally high-priced drugs at a reduced price (Frakt). Constructing alternatives>GET ANSWER